Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.28 USD -1.19% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Aurinia Pharmaceuticals Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aurinia Pharmaceuticals Inc
Cost of Revenue Peer Comparison

Comparables:
B
DRUG
TH
RPTX
COV
EDT

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Cost of Revenue
-$28.1m
CAGR 3-Years
-258%
CAGR 5-Years
N/A
CAGR 10-Years
-98%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Cost of Revenue
-$19.4m
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
-21%
Repare Therapeutics Inc
NASDAQ:RPTX
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Covalon Technologies Ltd
XTSX:COV
Cost of Revenue
-CA$12.7m
CAGR 3-Years
9%
CAGR 5-Years
-1%
CAGR 10-Years
-18%
Spectral Medical Inc
TSX:EDT
Cost of Revenue
-CA$1.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Aurinia Pharmaceuticals Inc's Cost of Revenue?
Cost of Revenue
-28.1m USD

Based on the financial report for Sep 30, 2024, Aurinia Pharmaceuticals Inc's Cost of Revenue amounts to -28.1m USD.

What is Aurinia Pharmaceuticals Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-98%

Over the last year, the Cost of Revenue growth was -178%. The average annual Cost of Revenue growth rates for Aurinia Pharmaceuticals Inc have been -258% over the past three years , and -98% over the past ten years .

Back to Top